Outcomes associated with sodium glucose co-transporter 2 inhibitors in anticoagulated atrial fibrillation patients

FUNDING ACKNOWLEDGEMENTS: Type of funding sources: None. BACKGROUND: Sodium glucose co-transporter 2 inhibitors (SGLT2i) have been associated with favourable outcomes in patients with heart failure. Studies also indicate a reduced risk of atrial fibrillation (AF). PURPOSE: We performed an explorator...

Descripción completa

Detalles Bibliográficos
Autores principales: Fawzy, A M, Bisson, A, Fauchier, L, Lip, G Y H
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2023
Materias:
10.2 - Epidemiology, Prognosis, Outcome
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10206686/
http://dx.doi.org/10.1093/europace/euad122.033

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10206686/
http://dx.doi.org/10.1093/europace/euad122.033

Ejemplares similares